Ignite Creation Date:
2024-05-06 @ 3:10 PM
Last Modification Date:
2024-10-26 @ 1:44 PM
Study NCT ID:
NCT04546009
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2024-06-05
First Post:
2020-09-08
Brief Title:
A Study Evaluating the Efficacy and Safety of Giredestrant Combined With Palbociclib Compared With Letrozole Combined With Palbociclib in Participants With Estrogen Receptor-Positive HER2-Negative Locally Advanced or Metastatic Breast Cancer persevERA Breast Cancer
Sponsor:
Hoffmann-La Roche
Organization:
Hoffmann-La Roche
Key Dates - Follows AllAPIJSON File Order
Start Date:
2020-10-09
Start Date Type:
ACTUAL
Primary Completion Date:
2025-03-31
Primary Completion Date Type:
ESTIMATED
Completion Date:
2027-03-18
Completion Date Type:
ESTIMATED
First Submit Date:
2020-09-08
First Submit QC Date:
September 8 2020
Study First Post Date:
2020-09-11
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-09-27
Last Update Post Date:
2024-06-05
Last Update Post Date Type:
ACTUAL